Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations

ABSTRACT: This study aims to investigate the efficacy and safety of the combination of pemetrexed and gemcitabine in heavily pre-treated, chemotherapy resistant colorectal cancer patients with KRAS mutations.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Cancer Stage Iv,Treatment Resistant Metastatic Colorectal Cancer With Kras Mutations,Colorectal Cancer,Colorectal Cancer Metastatic,Colorectal Neoplasms

PROVIDER: 2088056 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR